<table sstyle="width:80%" align="center" border=1>
<tr>
<th>mv</th>
<th>dw</th>
<th>HMMCrowd</th>
</tr>
<tr>
<td width=33%>
[0, 8] Plasma AGE-peptides and C-peptide<br>[31, 36] circulatory AGE-peptide levels<br>[130, 152] glucose, HbA1c, triglyceride, cholesterol, insulin, C-peptide, thiamine pyrophosphate, pyridoxal phosphate and AGE- peptides<br>[157, 160] AGE-peptides<br>[178, 181] AGE-peptides<br>[215, 216] HbA1c<br>[229, 232] C-peptide<br>[245, 249] plasma AGE-peptides<br>[290, 293] AGE-peptides<br>[305, 309] C-peptide.<br></td>
<td width=33%>
[0, 8] Plasma AGE-peptides and C-peptide<br>[31, 36] circulatory AGE-peptide levels<br>[43, 58] effects of thiamine (vitamin B1) and pyridoxine (vitamin B6) therapy.<br>[130, 152] glucose, HbA1c, triglyceride, cholesterol, insulin, C-peptide, thiamine pyrophosphate, pyridoxal phosphate and AGE- peptides<br>[157, 160] AGE-peptides<br>[178, 181] AGE-peptides<br>[215, 216] HbA1c<br>[229, 232] C-peptide<br>[245, 249] plasma AGE-peptides<br>[290, 293] AGE-peptides<br>[305, 309] C-peptide.<br></td>
<td width=33%>
[0, 8] Plasma AGE-peptides and C-peptide<br>[31, 36] circulatory AGE-peptide levels<br>[43, 58] effects of thiamine (vitamin B1) and pyridoxine (vitamin B6) therapy.<br>[130, 152] glucose, HbA1c, triglyceride, cholesterol, insulin, C-peptide, thiamine pyrophosphate, pyridoxal phosphate and AGE- peptides<br>[157, 160] AGE-peptides<br>[178, 181] AGE-peptides<br>[215, 216] HbA1c<br>[229, 232] C-peptide<br>[245, 249] plasma AGE-peptides<br>[290, 293] AGE-peptides<br>[305, 309] C-peptide.<br></td>
</tr>
